Joffre F, Levade M, Portalez D, Boccalon H, Puel P
J Mal Vasc. 1982;7 Suppl 4:391-2.
The advent and rapid strides made in the use of percutaneous intraluminal angioplasty (P.I.A.) in the treatment of chronic obliterating arteriopathies of the lower limbs have provoked a great deal of discussion. The exact place of this technique among the various therapies available is assessed in a different manner by radiologists, angiologists, and vascular surgeons. This report attempts to supply answers to two questions posed by certain authors in a more or less implicit manner: what is the importance of P.I.A. in relation to other therapeutic methods, and does P.I.A. have a marked diminishing effect on the need for surgery?
经皮腔内血管成形术（P.I.A.）在治疗下肢慢性闭塞性动脉病方面的出现及迅速发展引发了诸多讨论。放射科医生、血管病医生和血管外科医生对该技术在现有各种治疗方法中的确切地位有着不同的评估方式。本报告试图回答某些作者或多或少含蓄提出的两个问题：与其他治疗方法相比，经皮腔内血管成形术的重要性如何，以及经皮腔内血管成形术对手术需求是否有显著的减少作用？
